Phase 1 Parkinson Disease (PD) Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

Clinical Study to Evaluate XS411 in Treatment of Early-onset Parkinson's Disease

Parkinson Disease (PD)

XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd.90 enrolled1 locationNCT07166757

Recruiting

Phase 1

Testing if PDR-001 Can Safely and Effectively Remove Harmful Brain Protein in Parkinson's Disease

Parkinson Disease (PD)

Ruijin Hospital12 enrolled1 locationNCT07157345